Android app Apple app link

Avidity Biosciences (RNA) Soars to All-Time High on Looming $12-Billion Merger with Novartis

By Yahoo! Finance   |   1 month ago
Avidity Biosciences (RNA) Soars to All-Time High on Looming $12-Billion Merger with Novartis

Avidity Biosciences, Inc. (NASDAQ:RNA) is a top-performing stock following news of a merger with Novartis worth $12 billion. Novartis plans to acquire Avidity at $72 per share to enhance its neuroscience franchise.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.